| ID | Sequence | Length | GC content |
|---|---|---|---|
| CUCCAUCUUGGAAUUGGGAGGAAGAGGGAGAGGGAGACCGGGACGAGAC… | 4598 nt | 0.6205 | |
| CUCCAUCUUGGAAUUGGGAGGAAGAGGGAGAGGGAGACCGGGACGAGAC… | 4659 nt | 0.6175 | |
| CUCCAUCUUGGAAUUGGGAGGAAGAGGGAGAGGGAGACCGGGACGAGAC… | 4937 nt | 0.6192 |
Enables mitogen-activated protein kinase kinase binding activity; neuropilin binding activity; and protein serine/threonine kinase activity. Involved in several processes, including focal adhesion assembly; intracellular signal transduction; and positive regulation of MAPK cascade. Located in cytoplasmic vesicle; cytosol; and nuclear lumen. Part of receptor complex. [provided by Alliance of Genome Resources, Jul 2025]
A study in humans demonstrated that the TAOK2 mRNA showed suggestively higher expression in platelets from patients with ST-segment elevation myocardial infarction (STEMI) compared to those with non-STEMI (NSTEMI) [Eicher et al. DOI:10.3109/09537104.2015.1083543]. A study in humans identified numerous differentially expressed genes in blood from myocardial infarction patients, including the TAOK2 which was mentioned in the introduction as a potential biomarker for MI [Zhao et al. DOI:10.3892/etm.2017.5580].